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Abstract
Background: The Gram-positive bacterium Staphylococcus saprophyticus is the second most frequent causative
agent of community-acquired urinary tract infections (UTI), accounting for up to 20% of cases. A common feature
of staphylococci is colonisation of the human skin. This involves survival against innate immune defenses including
antibacterial unsaturated free fatty acids such as linoleic acid which act by disrupting bacterial cell membranes.
Indeed, S. saprophyticus UTI is usually preceded by perineal skin colonisation.
Results: In this study we identified a previously undescribed 73.5 kDa cell wall-anchored protein of S.
saprophyticus, encoded on plasmid pSSAP2 of strain MS1146, which we termed S. saprophyticus surface protein F
(SssF). The sssF gene is highly prevalent in S. saprophyticus clinical isolates and we demonstrate that the SssF
protein is expressed at the cell surface. However, unlike all other characterised cell wall-anchored proteins of S.
saprophyticus, we were unable to demonstrate a role for SssF in adhesion. SssF shares moderate sequence identity
to a surface protein of Staphylococcus aureus (SasF) recently shown to be an important mediator of linoleic acid
resistance. Using a heterologous complementation approach in a S. aureus sasF null genetic background, we
demonstrate that SssF is associated with resistance to linoleic acid. We also show that S. saprophyticus strains
lacking sssF are more sensitive to linoleic acid than those that possess it. Every staphylococcal genome sequenced
to date encodes SssF and SasF homologues. Proteins in this family share similar predicted secondary structures
consisting almost exclusively of a-helices in a probable coiled-coil formation.
Conclusions: Our data indicate that SssF is a newly described and highly prevalent surface-localised protein of S.
saprophyticus that contributes to resistance against the antibacterial effects of linoleic acid. SssF is a member of a
protein family widely disseminated throughout the staphylococci.
Background
Urinary tract infections (UTIs) are a universal source of
human morbidity, with millions of cystitis and pyelone-
phritis episodes reported annually [1]. An estimated 40-
50% of all women will experience at least one UTI in their
lifetime, and one in three women will have had at least
one clinically diagnosed UTI by the age of 24 [2]. Direct
health care costs due to UTI exceed $1 billion each year in
the USA alone [2]. Staphylococcus saprophyticus, a
coagulase-negative staphylococcus, is the second most
common causative agent of community-acquired urinary
tract infection after Escherichia coli [3], and is responsible
for up to 20% of cases. S. saprophyticus is of particular sig-
nificance to sexually active young women, accounting for
over 40% of UTI in this demographic [4]. S. saprophyticus
UTI symptoms mirror those of E. coli [5] and recurrence
is common, affecting 10-15% of infected women [6].
Three cell wall-anchored proteins, featuring a conserved
characteristic C-terminal LPXTG motif, have previously
been identified in S. saprophyticus. These proteins (i.e. SdrI,
UafA and UafB) are all involved in adhesion [7-9], a crucial
first step in the colonisation process. S. saprophyticus also
possesses non-covalently surface-associated Aas [10,11]
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and Ssp [12] proteins that are implicated in virulence.
Other than surface proteins, S. saprophyticus produces
abundant urease which contributes to its ability to grow in
urine [13]. Other putative virulence factors include cell sur-
face hydrophobicity [14], slime [15] and D-serine deami-
nase [16].
Apart from rare complications, S. saprophyticus is only
known to infect the urinary system [17-19]. The primary
niches of this organism are in the human gastrointestinal
and genitourinary tracts [4,20]. S. saprophyticus UTI is
often preceded by colonisation of the perineal area; thus it
can survive despite the innate immune defences of the
skin. In this study, we have identified a previously unde-
scribed LPXTG motif-containing cell wall-anchored pro-
tein of S. saprophyticus, termed SssF. The sssF gene is
plasmid-encoded in S. saprophyticus strains ATCC 15305
and MS1146 and is highly prevalent in clinical isolates.
We show that SssF belongs to a family of proteins con-
served among staphylococcal species and contributes to
survival against the staphylocidal free fatty acid linoleic
acid - a component of the human innate immune defence
system.
Results
Analysis of plasmid pSSAP2
S. saprophyticus strain MS1146, a clinical UTI isolate, has
been described previously [7]. Its genome contains three
plasmids - pSSAP1, pSSAP2 and pSSAP3. Sequence analy-
sis of the 36 907 bp pSSAP2 plasmid revealed the presence
of 35 predicted protein-coding genes, six pseudogenes and
a mean G + C content of 29.9% (Figure 1 and Additional
file 1: Table S1). Like other staphylococcal plasmids pre-
viously described, pSSAP2 has a mosaic structure with evi-
dence of multiple insertions and deletions of discrete
sequence blocks.
Plasmid pSSAP2 contains the repA gene and an
approximately 17 kb region (from position 4 124 to 21
247) which share 96% and 97-99% nucleotide identity,
respectively, with the chromosome of S. saprophyticus
ATCC 15305 (Figure 1). A large proportion of the pro-
teins encoded in this region are of unknown function or
hypothetical, with the exception of a putative permease
and several analogues of enzymes of the ribulose mono-
phosphate pathway (Additional file 1: Table S1). Of note,
the corresponding region in S. saprophyticus ATCC
15305 is longer (26 kb) and contains an arsenic resistance
operon arsRBC and a putative lipase, both absent from
pSSAP2. This region is also framed by two copies of the
IS element IS431, which is frequently involved in the
recombination-mediated integration of transposons and
plasmids in methicillin-resistant S. aureus (MRSA) chro-
mosomes [21,22]. Therefore, this region is likely to be an
integrative plasmid of strain ATCC 15305; positioned
upstream is a truncated integrase (SSP1642), for which
an intact copy can be found in the S. saprophyticus
MS1146 chromosome (Figure 1).
Another region of pSSAP2, ranging from position 21
529 to 33 235, shares ~99% nucleotide identity with
plasmid pSSP1, which was originally described from
S. saprophyticus ATCC 15305 [8]. The most notable fea-
ture of this region is the presence of a gene encoding
for a LPXTG domain containing protein that we have
designated sssF (see below).
Sequence analysis of SssF staphylococcal homologues
The S. saprophyticus MS1146 sssF gene is 1962 bp in
length and the full-length translated SssF (S. saprophyti-
cus surface protein F) protein contains 654 residues with
a predicted molecular mass of 73.5 kDa (Figure 2A). SssF
contains a predicted signal peptide of 45 residues (Sig-
nalP) [23] and an LPDTG anchor motif at the C terminus
(Figure 2A), involved with covalent attachment of the
mature protein to the cell wall. No conserved functional
protein domains were detected, except for a possible
albumin-binding GA module (Pfam PF01468, residues
58-109, E-value = 0.00039).
Sequence searches using the SssF amino acid sequence
revealed similar proteins in other staphylococci. As
expected, the SssF homologue encoded by pSSP1 in
S. saprophyticus ATCC 15305 is near-identical at the pro-
tein level with only seven amino acid substitutions. Of
note, every other sequenced staphylococcal genome con-
tains an sssF-like gene, all chromosomally located except
in S. saprophyticus (Additional file 2: Figure S1). Multiple
alignment of the C-terminal regions (corresponding to the
C-terminal 402 residues of SssF sequence) of one repre-
sentative SssF-like protein from each sequenced staphylo-
coccal species demonstrates there is variation from blocks
of conserved and similar residues to regions of less similar
sequence. This showed an overall protein identity ranging
from 30.3-47.6%, versus Staphylococcus pseudintermedius
HKU10-03 and Staphylococcus carnosus TM300, respec-
tively, and an average amino acid identity of approximately
37% with the remaining SssF-like proteins. In terms of
protein sequence similarity, these values range from 41.7%
(S. pseudintermedius HKU10-03) to 84.4% (S. carnosus
TM300). The N-terminal sequences are considerably
more divergent.
All SssF-like proteins have a predicted signal peptide of
between 35 and 45 residues, according to SignalP predic-
tions. It is noted that the annotated Staphylococcus hae-
molyticus JCSC1435 SssF-like protein has an incorrectly
called start codon, artifactually truncating the signal pep-
tide sequence. All of the SssF-like proteins have a C-
terminal sortase motif, implying cell surface localisation.
Of the ten illustrated in Additional file 2: Figure S1, four
have the canonical LPXTG motif, five have an alanine
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residue in the fourth position, and the Staphylococcus
lugdunensis protein has a serine in this position.
Structural prediction of SssF
Secondary structure predictions using PSI-PRED [24]
indicate that SssF contains long, almost uninterrupted
segments of a-helices (Figure 2B), which are likely to
wrap around each other forming a rope-like coiled-coil
structure. In order to predict its three-dimensional fold
we carried out a fold-recognition analysis of SssF
sequence using Phyre [25] (Protein Homology/AnalogY
Recognition Engine). This server allows a pairwise align-
ment of the SssF sequence to a library of known protein
structures available from the Structural Classification of
Proteins (SCOP) [26] and the Protein Data Bank (PDB)
[27] databases and generates preliminary models of the
protein by mapping the sequence onto the atomic coor-
dinates of different templates. Although SssF shares very
low sequence identity with proteins in the PDB (range
from 5-9%), this analysis identified several structural
homologues of SssF with a confidence level of 100%. All
the structures identified as likely analogues of SssF corre-
spond to proteins that have a coiled-coil fold, including
various types of the filamentous proteins such as tropo-
myosin [28] (PDB code: 1C1G) or alpha-actinin [29]
(PDB code 1HCI) (Figure 2C), strongly suggesting that
this protein shares a similar three-dimensional structure.
Each of the SssF-like proteins (complete mature forms)
of the other ten staphylococcal species indicated in Addi-
tional file 2: Figure S1 is also predicted to almost exclu-
sively consist of a-helical coiled-coils with the same
Phyre-predicted structural analogues as SssF (data not
shown).
The sssF gene is highly prevalent in S. saprophyticus
To assess the prevalence of sssF in S. saprophyticus we
used PCR to screen our collections of clinical isolates
originating from Australia, Germany and the USA. The
sssF gene was detected in 84.6% (55/65) of Australian
isolates, 90.9% (10/11) of American isolates and 88.3%
(53/60) of German isolates.
SssF is expressed at the S. saprophyticus cell surface
In order to study the cellular localisation and function of
the SssF protein, we generated an isogenic S. saprophyticus
MS1146 sssF mutant (MS1146sssF) by insertional inactiva-
tion with a group II intron using the TargeTron system.
We then complemented the sssF mutation by the introduc-
tion of a pPS44 staphylococcal vector containing the cloned
sssF gene, to create MS1146sssF(pSssF). Western blot ana-
lysis of whole-cell lysates from S. saprophyticus MS1146,
MS1146sssF and MS1146sssF(pSssF) using rabbit polyclo-
nal anti-SssF serum raised against a recombinant truncated
SssF protein, demonstrated expression of SssF in MS1146
but not MS1146sssF. Complementation of sssF restored
SssF expression in MS1146sssF(pSssF) (Figure 3A). The
Figure 1 Structure of the S. saprophyticus MS1146 plasmid pSSAP2 compared to the S. saprophyticus ATCC 15305 plasmid pSSP1, and
the chromosomes of S. saprophyticus ATCC 15305 and S. saprophyticus MS1146. Arrows represent CDS coloured according to their
predicted function: no specific function (light blue); replication (pink); transposase for IS431 (yellow); other transposase (orange); integrase
(brown); virulence-related (red); hypothetical protein (grey); and pseudogenes (black). Similarity regions between sequences are coloured in a
gradient of blue, reflecting the percentage of nucleotide identity ranging from 91 to 100%, as illustrated on the scale on the top right of the
figure.
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anti-SssF serum was used in conjunction with immunogold
labeling and electron microscopy to demonstrate localisa-
tion of the SssF protein at the cell surface. MS1146 and
MS1146sssF(pSssF) exhibited abundant gold labeling
whereas MS1146sssF was devoid of labeling (Figure 3B).
SssF does not mediate adhesion to uroepithelial cells or
colonisation of the mouse bladder
Initial investigations into the function of SssF found no
evidence of adhesion (to T24 and 5637 human bladder
carcinoma cells [American Type Culture Collection;
ATCC], exfoliated human urothelial cells or a wide range
of ECM and other molecules, including human serum
albumin), invasion of 5637 bladder cells, cell surface
hydrophobicity modulation, biofilm formation or serum
resistance that could be attributable to SssF (data not
shown). Strain MS1146 and derivatives colonised the
mouse bladder in similar numbers in a mouse model of
UTI (4.8-5.8 × 106 c.f.u. per 0.1 g bladder tissue), indicat-
ing that SssF does not contribute to colonisation in this
infection model.
S. saprophyticus strains containing the sssF gene are more
resistant to linoleic acid than those lacking sssF
The above results prompted us to analyse the sequences
of the family of SssF-like proteins to predict a function
Figure 2 Sequence analysis of SssF. (A) Primary structure of the S. saprophyticus MS1146 SssF protein. The putative signal peptide, the
corresponding gene region used for PCR screening, the region used in the multiple alignment (Additional file 2: Figure S1), the region used for
polyclonal antibody raising and the LPDTG sortase anchor motif are indicated. (B) Structural prediction of the mature form of SssF. Residues
coloured in red and in blue are predicted to adopt a-helical and b-strand conformations respectively. (C) Crystal structures of tropomyosin and
alpha-actinin identified as likely structurally similar to SssF.
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for SssF. The staphylococcal SssF-like proteins are all
hypothetical proteins of unknown function except for
SssF, which contributes to resistance of S. aureus to
linoleic acid [30]. The mechanism of this phenotype
remains unexplored. To determine whether SssF had a
similar phenotype to the S. aureus SasF protein, linoleic
acid survival assays were performed with S. saprophyti-
cus MS1146 wild-type, MS1146sssF and MS1146sssF
(pSssF) strains. No differences in survival among the
strains were observed (data not shown). Following the
lack of an observable phenotype for SssF in S. saprophy-
ticus MS1146, we modified the linoleic acid emulsion
assay to examine the survival of S. saprophyticus isolates
that contain and do not contain the sssF gene in the
presence of 0.85 M NaCl. Under these conditions, we
observed a 30-fold difference in survival between the
sssF+ and sssF- strains (P = 0.008; Figure 4). Using this
modified protocol, we still observed no difference
between the S. saprophyticus MS1146 wild-type and sssF
mutant at linoleic acid concentrations of up to 25 mM
(data not shown).
SssF is associated with resistance to linoleic acid
Survival assays were carried out with a S. aureus SH1000
genetic background, with the aim of determining if SssF
could restore linoleic acid resistance of a S. aureus
SH1000sasF knockout mutant (Figure 5). In agreement
with a previous study [30], mutation of sasF in S. aureus
SH1000 resulted in enhanced sensitivity to linoleic acid
and this effect could be complemented by the introduction
of a sasF-containing plasmid [SH1000sasF(pSKSasF)].
When the sssF gene from S. saprophyticus MS1146 was
introduced into S. aureus SH1000sasF, resistance to lino-
leic acid was also restored, demonstrating that SssF contri-
butes to the survival of S. aureus in the presence of
linoleic acid.
Discussion and conclusion
S. saprophyticus is a major cause of community-acquired
UTI in young women. Knowledge of the virulence mechan-
isms of S. saprophyticus has advanced in recent years, parti-
cularly with the acquisition and analysis of whole genome
sequence data. The majority of acknowledged virulence
Figure 3 Expression of SssF. (A) Western blot analysis of whole-cell lysates prepared from S. saprophyticus MS1146, MS1146sssF and MS1146sssF
(pSssF) using a polyclonal antiserum directed against SssF. Lanes: M, Novex Sharp Pre-stained protein marker (Invitrogen); 1, MS1146; 2,
MS1146sssF; 3, MS1146sssF(pSssF). The position of SssF is indicated. Expression of SssF was detected in wild-type S. saprophyticus strain MS1146
and the sssF complemented strain but not in the isogenic sssF mutant. (B) Immunogold TEM of S. saprophyticus MS1146, MS1146sssF and
MS1146sssF(pSssF). Expression of SssF at the cell surface of S. saprophyticus MS1146 was demonstrated by abundant labeling with SssF-gold
particles. In contrast, the sssF isogenic knockout mutant was devoid of gold labeling. Complementation of the sssF mutation restored and
enhanced surface expression of SssF. Bars, 500 nm.
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factors of S. saprophyticus are proteins tethered to the cell
surface, which with the exception of the Ssp lipase [12], are
all involved in adhesion: Aas is an autolysin that also binds
to fibronectin [10]; UafA adheres to uroepithelial cells via
an unidentified ligand [8]; SdrI binds to collagen I and
fibronectin [9,31] and UafB binds to fibronectin, fibrinogen
and urothelial cells [7]. Here we have identified another cell
wall-anchored protein produced by S. saprophyticus that
we have termed SssF - the sixth surface protein described
for this species.
The sssF gene was identified in the sequence of the
pSSAP2 plasmid of S. saprophyticus MS1146 due to the
presence of the canonical LPXTG sortase motif in the
translated protein sequence. A copy of the sssF gene is
also located on the pSSP1 plasmid of S. saprophyticus
ATCC 15305 (99% nucleotide identity; Figure 1), but it
was not acknowledged as encoding an LPXTG motif-
containing protein [8]. We recently characterised
another plasmid-coded LPXTG motif-containing protein
of S. saprophyticus MS1146, UafB, as an adhesin [7]. We
first sought to investigate whether SssF was another
adhesin, since a considerable proportion of characterised
Gram-positive covalently surface anchored proteins have
adhesive functions [32], including every other known
S. saprophyticus LPXTG motif-containing protein. No
evidence of an adhesion phenotype for SssF was
detected.
SssF protein sequence searches with the BLAST data-
base provided an output of uncharacterised staphylococcal
proteins with a maximum 39% amino acid identity to SssF
across the entire protein sequence, mostly annotated as
Figure 4 Agar plate-based linoleic acid survival assay. Relative
survival of sssF+ (including MS1146) and sssF- S. saprophyticus strains
on BHI agar medium supplemented with 0.85 M NaCl and
containing 0 mM (A) or 5 mM (B) linoleic acid. The presence of the
sssF gene is associated with increased (30-fold) resistance to linoleic
acid. Serial dilutions of overnight S. saprophyticus cultures (2.5 μl)
were spotted onto BHI agar + 0.85 M NaCl, containing 0 mM and 5
mM linoleic acid, 1% ethanol. The neat to 10-5 dilutions are as
indicated.
Figure 5 SssF activity is detected in a S. aureus heterologous
complementation approach. (A) Relative survival of S. aureus
SH1000 wild-type, SH1000sasF isogenic mutant and sasF, sssF and
vector only complemented strains on agar medium containing 1
mM linoleic acid. Heterologous complementation of the S. aureus
SH1000 sasF mutant with the sssF gene from S. saprophyticus
MS1146 restores survival in these conditions. Serial dilutions of
overnight S. aureus cultures (2.5 μl) were spotted onto BHI agar, pH
6.0, containing 0 mM and 1 mM linoleic acid, 1% ethanol. The neat
to 10-6 dilutions are as indicated. Shown are representative images
from one of multiple experiments. (B) Graph showing the relative
survival of S. aureus SH1000 and SH1000 derivates using data from
Figure 5A. Colonies were counted after overnight incubation. Error
bars represent ± SEM. Results from multiple experiments were
analysed with Student’s t test.
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hypothetical cell wall-anchored proteins. In contrast to
S. saprophyticus, the genes encoding these SssF-like pro-
teins are located on the chromosome, rather than on a
plasmid, in every other sequenced staphylococcal species.
Some of these staphylococcal SssF-like proteins contain
atypical sortase motifs. At this stage it is not known
whether all of these proteins are sorted to the cell surface
efficiently, but SasF has been shown to be associated with
the cell wall of S. aureus 8325-4 even with the non-classi-
cal LPKAG sortase motif [33]. There was a distinct lack of
phenotypic data for these SssF-like proteins until a role for
SasF was recently uncovered. Kenny et al. [30] observed
that sasF was the most upregulated gene in S. aureus
MRSA252 microarray and qRT-PCR experiments upon
challenge with linoleic acid. The protective function of
SasF was apparent when examined in a linoleic acid emul-
sion agar plate-based bacterial survival assay. Our hypoth-
esis focused on the possibility that SssF possessed a similar
function to SasF, but no linoleic acid resistance phenotype
for SssF was observed in the S. saprophyticus MS1146
genetic background. Using the linoleic acid emulsion agar
plate bacterial survival assay in the presence 0.85 M NaCl,
we observed a higher survival amongst S. saprophyticus
strains that harbour the sssF gene than those that lack
sssF. We then successfully expressed SssF heterologously
in a S. aureus SH1000sasF host and demonstrated restored
resistance to linoleic acid. We found S. saprophyticus
MS1146 to be intrinsically more resistant to linoleic acid
than S. aureus SH1000. This remains to be explored but
could be due to a number of species/strain specific factors
including the action of redundant S. saprophyticus
MS1146 resistance mechanisms or variations in surface
components such as capsule or teichoic acids.
We found that the survival of S. aureus SH1000 and its
derivatives was markedly increased in the presence of lino-
leic acid at pH 6.0 compared to pH 7.4. This result is con-
sistent with previous studies of the staphylococcal fatty
acid modifying enzyme (FAME), an unidentified but par-
tially characterised protein secreted by most staphylococci
which detoxifies free fatty acids by esterifying them to an
alcohol [34,35]. The FAME of S. aureus and S. epidermidis
demonstrate optimal activity at pH 6.0, and have little
activity at pH 7.4 [35,36]. This is congruent with human
skin having a slightly acidic pH of 5.5-6 [37]. RP-HPLC
experiments using linoleic acid and crude protein extracts
demonstrated that SssF activity is distinct from FAME
activity (data not shown). Other antimicrobial fatty acids
such as sapienic acid have yet to be examined as substrates
for SssF or SasF. We hypothesise that some or all of the
other uncharacterised SssF-like proteins exhibit fatty acid
resistance activity, but this remains to be demonstrated
experimentally.
There are precedents for bacterial surface structures
that provide protection against bactericidal free fatty
acids. Gram-positive bacterial cell wall teichoic acids pro-
vide protection against free fatty acid mediated killing of
S. aureus [38]. The IsdA protein of S. aureus reduces bac-
terial hydrophobicity when expressed at the cell surface
under the cue of iron starvation to resist fatty acid mem-
brane attack and also promotes fatty acid resistance of
S. aureus in a volunteer human skin survival model [39].
Our studies however found that expression of SssF does
not influence cell surface hydrophobicity of S. saprophyti-
cus, and this corresponds with matching data for SasF
and S. aureus [30].
No conserved motifs that might predict the functional
residues of SssF-like proteins were identified. The observa-
tion that the SssF-like proteins are structurally related to
myosin is noteworthy, especially in light of the recent
characterisation of myosin cross-reactive antigens of Strep-
tococcus pyogenes and Bifidobacterium breve as fatty acid
hydratases [40,41]. These enzymes act to detoxify unsatu-
rated free fatty acids, including linoleic acid. Homologous
proteins with modest primary sequence identity but simi-
lar tertiary structures are acknowledged in both bacterial
[42] and mammalian [43] lipid-binding protein families. It
is possible that conserved tertiary protein structure
between SssF-like proteins contributes to their function.
S. saprophyticus is a uropathogen, but SssF is unlikely
to have evolved to facilitate survival in the urinary tract.
A common trait of staphylococci is skin colonisation.
Staphylocidal free fatty acids (especially unsaturated) are
present on human skin [44] and are also active in staphy-
lococcal abscesses [45]. Furthermore, linoleic acid is one
of the most abundant polyunsaturated fatty acids on
human skin [46], and is also present in vaginal secretions
[47]. SssF may be an important determinant for survival
of S. saprophyticus in the events preceding urethral entry
in community-acquired UTI - colonisation of perineal
and periurethral tissue. This would account for the
absence of SssF involvement in the mouse model of UTI,
in which the inocula are delivered directly into the
bladder.
The location of sssF on a plasmid in both sequenced S.
saprophyticus strains is intriguing, particularly as every
other staphylococcal SssF-like protein is chromosomally
encoded. It has been observed that many genes that are
located on plasmids encode for traits which have extracellu-
lar functions [48], and sssF falls into this category. Further-
more, plasmid genes have often been noted to confer
selective advantage to the bacteria in some environmental
niches but not others [49]. Every pathogenic staphylococcal
species known to carry a chromosomal sssF-like gene is
known to commensally inhabit the skin, and this can be
considered their main niche. S. saprophyticus, on the other
hand, primarily resides in the genitourinary and gastroin-
testinal tracts [4,20]. It is feasible that since human skin is
not the major habitat of S. saprophyticus, sssF has been
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retained as an accessory gene required for survival on the
skin during non-UTI periods. Nonetheless, it may still be
the case that sssF is found on the chromosome of some S.
saprophyticus strains.
SssF represents the fourth LPXTG motif-containing pro-
tein described in S. saprophyticus. We present here evi-
dence that the S. saprophyticus SssF protein has a role in
the protection against free fatty acid mediated killing, and
that it is a member of a newly identified protein family
broadly distributed throughout the Staphylococcus genus.
Materials and methods
Bacterial strains and plasmids
The bacterial strains and plasmids used in this study are
listed in Table 1. The clinical S. saprophyticus isolate
collection used in this study is as previously described
[7]. In addition, 60 clinical isolates from Germany were
also tested. S. saprophyticus ATCC 15305 was described
previously [8]. Staphylococcal strains were cultured in/
on Brain Heart Infusion (BHI) broth/agar (Oxoid) sup-
plemented with erythromycin or chloramphenicol
(10 μg ml-1) as required. E. coli strains were cultivated
in/on Luria-Bertani (LB) broth/agar supplemented with
ampicillin (100 μg ml-1) as required.
DNA manipulations and genetic techniques
Genomic and plasmid DNA were isolated as previously
described [7]. PCR assays to determine the presence of
sssF (primers 1127 and 1128) were performed using
Taq DNA polymerase (NEB) under the following con-
ditions: 2 min at 94°C, 25 cycles of 15 s at 94°C, 30 s
at 55°C, 20 s at 72°C, 1 cycle of 3 min at 72°C, 4°C
hold. Primers were synthesised by Sigma and are listed
in Table 2. PCR amplification of the sssF gene was per-
formed using Phusion Hot Start DNA Polymerase
(Finnzymes).
Bioinformatic analysis and identification of sssF
The sssF gene was identified in plasmid pSSAP2 of
S. saprophyticus MS1146. The final pSSAP2 sequence was
finished to Q40 standard with an average Sanger read
depth of ~23 × coverage, which corresponds to an esti-
mated number of four pSSAP2 plasmid copies per cell,
based on the observed chromosomal read coverage (data
not shown). Annotation of plasmid pSSAP2 was carried
out manually using Artemis [55] and BLAST [56] similar-
ity searches of publicly available sequence databases. The
complete nucleotide sequence of S. saprophyticus plasmid
pSSAP2 is available from the GenBank/EMBL/DDBJ data-
base under accession number HE616681. The multiple
alignment (Additional file 2: Figure S1) was created with
CLUSTAL W2 [57] and edited with Jalview [58]. Figure 1
was produced using Easyfig [59].
Construction and complementation of staphylococcal
mutants
Plasmid construct pNK24 (Table 1), specifically retar-
geted to the sssF gene of S. saprophyticus MS1146, was
prepared using the Sigma TargeTron Gene Knockout
System, as per the manufacturer’s instructions. Retarget-
ing PCR primer sequences (1001-1003, Table 2) were
determined by the TargeTron online design site, followed
by a retargeting PCR and cloning of the PCR product
into the provided shuttle vector, pNL9164 (Table 1). The
construct was sequenced to verify correct inserts using
primer 1011 (Table 2). The retargeted plasmid was then
purified with a Qiagen Maxiprep kit and introduced into
S. saprophyticus MS1146 by protoplast transformation as
previously described [10], followed by CdCl2 induction
and colony PCR screening to identify the sssF mutant
(MS1146sssF). The S. aureus SH1000 sasF gene was also
interrupted with the TargeTron system as above, using
primers 2065-2067 (Table 2). The retargeted plasmid
(pNK41, Table 1) was passaged through a restriction-
deficient S. aureus strain (RN4220), then electroporated
into S. aureus SH1000 and induced to create the sasF
mutant (SH1000sasF). For complementation of the
S. saprophyticus MS1146 sssF mutation, the sssF gene
was initially amplified from S. saprophyticus MS1146
(primers 839 and 840, Table 2) and cloned into the
BamHI site of pSK5632, forming plasmid pSKSssF. Plas-
mid pPS44 was digested with BamHI/XbaI and the vector
part was ligated with the BamHI/XbaI sssF-containing
fragment from pSKSssF to generate plasmid pSssF. Plas-
mid pSssF was used to transform S. carnosus TM300,
re-isolated and then introduced into S. saprophyticus
MS1146sssF by protoplast transformation. For comple-
mentation of the SH1000sasF mutation, sasF from S. aur-
eus SH1000 was PCR amplified (primers 2084 and 2085,
Table 2) and cloned into the HindIII site of pSK5632 to
form plasmid pSKSasF, followed by electroporation of
SH1000sasF. SH1000sasF was heterologously comple-
mented with the S. saprophyticus MS1146 sssF gene by
the introduction of pSKSssF. S. aureus SH1000sasF con-
taining empty pSK5632 vector was also prepared as a
control.
Purification of truncated SssF, antibody production and
immunoblotting
For antiserum production, a 1330 bp segment from sssF
from S. saprophyticus MS1146 (Figure 2A) was amplified
with primers 873 and 874 (Table 2), digested with XhoI/
EcoRI and ligated into XhoI/EcoRI-digested pBAD/HisB.
The resultant plasmid (pSssFHis) contained the base
pairs 181-1510 of sssF fused to a 6 × His-encoding
sequence. This sssF sequence corresponds to amino resi-
dues 39-481 of the SssF sequence. Protein induction and
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purification, inoculation of rabbits, staphylococcal cell
lysate preparation and immunoblotting were performed
as described previously [7], except NuPAGE Novex 4-
12% Bis-Tris precast gels with NuPAGE MES SDS run-
ning buffer (Invitrogen) were used for the SDS-PAGE
and S. saprophyticus MS1146sssF-adsorbed rabbit anti-
SssF serum was used as the primary serum for the
Western blot.
Microscopy and image analysis
Immunogold labeling and transmission electron micro-
scopy (TEM) were performed as described previously
Table 1 Strains and plasmids used in this study
Strain or
plasmid
Description Reference or
source
E. coli strains
DH5a F- !80dlacZ∆M15 ∆(lacZYA-argF)U169 deoR recA1 endA1 hsdR17(rk- mk+) phoA supE44 l- thi-1 gyrA96 relA1 Grant et al. [50]
BL21 F- ompT hsdSB(rB- mB-) gal dcm Stratagene
MS2066 DH5a containing pSssFHis This study
MS2067 BL21 containing pSssFHis This study
S. saprophyticus
strains
ATCC 15305 Type strain (genome sequenced) Kuroda et al. [8]
MS1146 Clinical isolate AstraZeneca
MS1146sssF MS1146 isogenic sssF mutant This study
MS1146sssF(pSssF) Complemented MS1146 sssF mutant This study
S. aureus strains
SH1000 Functional rsbU-repaired derivative of S. aureus 8325-4 Horsburgh et al.
[51]
SH1000sasF SH1000 isogenic sasF mutant This study
SH1000sasF
(pSKSasF)
SH1000 sasF mutant complemented with sasF This study
SH1000sasF
(pSKSssF)
SH1000 sasF mutant complemented with sssF This study
SH1000sasF
(pSK5632)
SH1000 sasF mutant with empty pSK5632 vector This study
S. carnosus
strains
TM300 Wild-type SK311 Schleifer &
Fischer [52]
TM300(pSssF) TM300 containing pSssF This study
Plasmids
pBAD/HisB Cloning and protein expression vector, containing N-terminal 6 × His tag; Apr Invitrogen
pNL9164 E. coli/S. aureus TargeTron shuttle vector (temperature sensitive); Apr Emr Sigma
pSK5632 Cloning and expression E. coli/S. aureus shuttle vector; Apr Cmr Grkovic et al.
[53]
pPS44 Staphylococcal vector, contains replicon and cat gene of pC194; Cmr Wieland [54]
pSssFHis 1330 bp MS1146 sssF fragment, amplified with primers 873 and 874, digested with EcoRI/XhoI and cloned
into EcoRI/XhoI-digested pBAD/HisB, with in-frame N-terminal 6 × His tag; Apr
This study
pNK24 pNL9164 shuttle vector retargeted with primers 1001-1003, EBSU to knock out MS1146 sssF (TargeTron
system); Apr Emr
This study
pNK41 pNL9164 shuttle vector retargeted with primers 2065-2067, EBSU to knock out SH1000 sasF (TargeTron
system); Apr Emr
This study
pSKSssF 2394 bp fragment, including entire sssF gene from MS1146, amplified with primers 839 and 840 and cloned
into the BamHI site of pSK5632; Apr Cmr
This study
pSssF 2400 bp BamHI/XbaI fragment, containing sssF gene, subcloned from pSKSssF into BamHI/XbaI-digested
pPS44; Cmr
This study
pSKSasF 2175 bp fragment, including sasF gene from S. aureus NCTC 8325, amplified with primers 2084 and 2085 and
cloned into the HindIII site of pSK5632; Apr Cmr
This study
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[7], using 1:10 anti-SssF serum as the primary antibody.
No negative staining was performed.
Linoleic acid survival assay
S. aureus linoleic acid survival assays were performed
essentially as described by Kenny et al. [30]. Briefly,
serial dilutions of overnight cultures (2.5 μl spots) were
plated in duplicate onto BHI agar, pH 6.0, containing 0
mM or 1 mM linoleic acid. All agar media contained a
final concentration of 1% ethanol. Colonies were
counted after overnight incubation at 37°C. Mean values
were compared using Student’s t test. S. saprophyticus
survival assays were performed similarly, but with agar
plates containing 5 mM linoleic acid, supplemented
with 0.85 M NaCl.
Structural predictions of SssF
Secondary structure and three-dimensional fold predic-
tions were performed using PSI-PRED [24] and Phyre
[25], respectively.
Additional material
Additional file 1: Table S1. Predicted protein-coding genes of pSSAP2.
Additional file 2: Figure S1. ClustalW alignment of the C-terminal 402
amino acid residues of S. saprophyticus MS1146 SssF protein (61% of
entire sequence) with corresponding sequence from other
staphylococcal SssF-like proteins, showing clusters of amino acid
conservation. Only one representative protein from each species is
shown. Sequences are sorted (in descending order) by similarity to S.
saprophyticus MS1146 SssF sequence, which ranges from 31.1% (S.
pseudintermedius HKU10-03) to 48.5% (S. carnosus TM300). Jalview was
used to colour-code the alignment by percentage identity. The C-
terminal sortase anchor motifs are indicated by a red box. GenBank
accessions for the SssF-like proteins are as follows: S. carnosus TM300,
CAL29334; S. capitis SK14, EEE48467; S. caprae C87, EFS16450; S.
epidermidis RP62A, AAW53125; S. warneri L37603, EEQ79103; S.
haemolyticus JCSC1435, BAE03665; S. hominis SK119, EEK11979; S. aureus
NCTC 8325, ABD31969; S. lugdunensis HKU09-01, ADC86449; S.
pseudintermedius HKU10-03, ADV06726.
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